Therapeuticsmd, inc. (TXMD)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss

-193,487

-176,144

-166,100

-169,739

-147,721

-132,617

-114,653

-93,712

-80,170

-76,925

-78,334

-88,685

-90,102

-89,875

-84,521

-78,978

-85,112

-85,077

-83,896

-82,256

-65,928

-54,217

-46,293

-36,116

-31,226

-28,419

-25,767

-22,365

-28,206

-35,120

-38,978

-36,212

-25,428

-12,913

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of fixed assets

547

415

283

235

209

181

158

151

146

141

136

127

103

77

53

34

31

29

28

27

28

28

29

51

50

47

47

24

25

27

0

0

0

-

-

-

-

Amortization of intangible assets

220

197

175

155

131

112

96

83

76

71

68

63

59

54

48

43

36

32

28

25

24

23

17

15

12

10

15

21

24

28

0

0

0

-

-

-

-

Non-cash operating lease expense

1,194

1,062

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

(Recovery of) provision for doubtful accounts

102

307

79

345

275

216

234

60

28

4

264

2,059

2,287

2,524

2,246

438

245

22

29

23

1

-5

-61

-72

-31

-15

55

83

62

40

0

0

0

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,307

-17,895

-17,697

-17,697

-7,390

0

0

0

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,102

1,547

1,597

2,653

1,604

1,170

1,134

82

28

0

0

0

Share-based compensation

10,473

10,693

10,132

9,757

9,497

8,661

8,240

7,966

7,227

6,889

9,063

11,261

14,442

17,411

15,834

13,421

10,730

7,189

5,776

5,670

4,801

4,970

5,851

4,932

4,311

3,844

2,763

2,519

2,322

1,868

1,069

621

226

190

0

0

0

Amortization of deferred financing fees

1,055

856

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

260

656

1,052

1,447

1,451

0

0

0

-

0

0

0

-

-

-

-

Amortization of license fee

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock based expense for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

910

855

462

338

255

142

78

22

0

0

0

Loan guaranty costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

24

36

45

46

46

46

38

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

5,821

13,639

2,600

13,102

10,123

6,951

8,644

2,289

1,204

-167

-375

978

1,144

3,975

3,613

1,602

2,665

917

1,546

1,172

306

458

293

1,134

1,705

1,068

1,686

741

660

728

313

433

113

16

0

0

0

Inventory

9,651

8,593

8,154

5,613

3,334

1,782

1,084

466

282

409

450

530

381

386

-26

-365

-1

-491

-141

-204

38

138

-135

-53

-417

-571

192

685

795

1,027

544

202

-15

-29

0

0

0

Other current assets

-

-

-

-

-

-

2,369

1,836

2,674

4,434

501

349

20

-709

-228

155

387

773

139

-1,523

-857

-680

-738

150

1,471

1,386

1,855

1,535

10

-42

376

469

289

346

0

0

0

Other current assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

10

17

35

31

37

37

-402

-314

574

565

0

0

0

-

-

-

-

-

-

-

-

Accounts payable

3,349

-3,562

12,751

8,072

19,081

18,646

7,182

3,319

137

-3,260

-25

5,068

2,715

4,232

-1,077

-2,779

-2,804

-3,200

-347

3,488

3,166

4,212

3,176

285

1,227

472

1,440

1,352

1,233

1,334

774

460

485

188

0

0

0

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-522

-848

-1,287

-1,478

-1,079

-1,004

68

331

457

2,554

1,837

1,147

1,144

0

0

0

-

-

-

-

Accrued expenses and other current liabilities

12,144

13,675

3,839

11,348

9,224

9,107

11,217

4,604

1,435

1,599

-1,566

-1,119

1,774

84

1,856

411

1,286

3,698

1,875

2,558

2,607

239

2,595

2,144

1,255

2,875

1,895

849

982

639

431

796

534

594

0

0

0

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-166,645

-165,697

-143,045

-150,890

-125,325

-106,811

-99,472

-82,088

-75,279

-76,155

-70,968

-73,082

-70,264

-69,142

-70,133

-69,772

-79,298

-79,044

-77,719

-70,739

-55,964

-45,520

-35,004

-28,861

-25,965

-20,768

-20,005

-17,772

-13,794

-12,737

-10,615

-9,053

-6,657

-4,966

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES
Patent costs

1,460

1,441

1,425

1,433

1,366

1,105

1,074

832

799

765

743

819

862

845

842

733

472

419

511

452

526

586

374

539

455

439

375

269

274

206

97

58

20

8

0

0

0

Purchase of fixed assets

2,209

2,450

2,240

1,263

452

217

92

71

60

61

124

166

349

396

0

0

0

-

-

-

-

30

47

48

41

40

21

22

56

66

68

69

50

28

0

0

0

Payment of security deposit

-

-

-

-

-

175

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-23,689

-23,912

-3,849

-22,882

-21,983

-21,497

-21,178

-915

-872

-827

-867

-995

-1,225

-1,255

-1,314

-1,153

-712

-584

-515

-467

-522

-606

-526

-556

-600

-583

-396

-417

-331

-272

-155

133

-71

-37

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of options and warrants

80

108

538

637

1,722

1,666

1,236

1,129

64

212

222

223

394

989

1,621

1,719

2,011

1,232

620

549

312

345

340

311

70

30

6

31

25

191

0

0

0

-

-

-

-

Proceeds from revolving credit note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Repayment of revolving credit note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Proceeds from sale of common stock, net of costs

-

-

-

-

-

-

-

-

-

-

-

-

-

134,863

134,863

167,120

167,120

91,374

0

0

0

-

-

-

33,219

78,650

86,755

56,407

53,325

7,895

0

0

0

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

3,798

3,798

3,798

2,523

1,373

1,373

1,373

1,317

366

366

460

539

181

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from notes and loans payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,400

8,700

9,388

8,934

4,816

2,684

0

0

0

Proceeds from sale of membership units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Proceeds from Financing Agreement

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

0

0

0

-

-

-

-

-

-

-

-

Payment of deferred financing fees

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of bank line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

0

0

0

-

-

-

-

-

-

-

-

Repayment of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,691

6,491

6,491

6,541

1,850

248

248

200

200

0

0

0

Net cash provided by financing activities

237,548

188,826

112,225

202,232

162,843

162,787

162,357

140,914

69,975

72,584

72,594

4,022

2,917

137,225

137,858

170,212

170,449

92,973

92,360

102,898

102,741

43,298

42,957

30,536

33,190

73,989

79,820

51,298

52,710

14,436

10,771

10,168

6,905

4,707

0

0

0

Increase (decrease) in cash

47,213

-783

-34,669

28,459

15,534

34,477

41,706

57,910

-6,175

-4,398

758

-70,055

-68,571

66,827

66,410

99,286

90,438

13,344

14,124

31,691

46,254

-2,829

7,426

1,118

6,624

52,637

59,418

33,108

38,584

1,427

0

1,248

176

-296

0

0

0

Supplemental disclosure of cash flow information
Interest paid

21,766

17,787

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

212

193

222

206

17

37

8

2

0

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Warrants issued for financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,711

0

0

0

-

-

-

-

-

-

-

-